Don’t Overlook First-Gen Anti-Obesity Medications

With the explosive popularity of glucagon-like peptide 1 (GLP-1) agonists, physicians say a key avenue in treating obesity is being underutilized by many clinicians: First-generation anti-obesity medications (AOMs). “First-generation medications don’t get as much attention as the newer ones,” said Courtney Younglove, MD, an obesity specialist and founder of Heartland Weight Loss in Overland Park, … Read more

Many Sites Lack Info on Compounded GLP-1 RAs

More than a third of websites that advertise and sell compounded versions of popular drugs for diabetes and weight loss — such as Ozempic and Wegovy — falsely claim the compounded medications have been approved by the Food and Drug Administration (FDA), according to a recent research letter. Compounded drugs, such as those using the … Read more